Trial · NCT01263717
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Liver Fat | 6 months | Hepatic fat as measured by magnetic resonance (MR) spectroscopy, and expressed by normalizing lipid to water and expressing as a percent (lipid-to-water percent). |
| Primary | Visceral Adipose Tissue | 6 months | Change in visceral adipose tissue area as measured by single-slice computed tomography (CT) scan at the L4 vertebra. |
| Secondary | Intramyocellular Lipid | 6 months | Intramyocellular lipid (IMCL) as measured by magnetic resonance (MR) spectroscopy of the calf. Soleus IMCL normalized to creatinine (IMCL/Cr based on areas determined by spectroscopy) was measured. The change over 6 months is reported. |
| Secondary | Endogenous Growth Hormone Secretion | 6 months | Endogenous growth hormone (GH) concentrations measured by overnight frequent blood sampling every 20 minutes. Mean overnight GH concentration is given. |
| Secondary | Insulin Sensitivity | 6 months | In a subgroup of 1/2 of the subjects, euglycemic hyperinsulinemic clamp will be performed to assess insulin-stimulated glucose uptake. Insulin stimulated glucose uptake (M) calculated using the method of DeFronzo is shown. |
| Secondary | HbA1c | 6 months | Hemoglobin A1c. |
| Secondary | Insulin Like Growth Factor 1 (IGF-I) | 6 months | Insulin Like Growth Factor 1 (IGF-I). |
| Secondary | Lipid Panel | 6 months | Fasting lipids. Triglyceride value is given. |
| Secondary | Carotid Intimal Medial Thickness (cIMT) | 6 months | Carotid Intimal Medial Thickness (cIMT). |
| Secondary | Glucose Tolerance | 6 months | Glucose tolerance as measured by standard oral glucose tolerance test. 2-hour glucose is given. |
| Secondary | Adiponectin | 6 months | adiponectin. |
| Secondary | Hemostatic Markers | 6 months | Tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1) measured in serum. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01263717/registered